Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19
Patients with colon adenocarcinoma (COAD) are at a higher probability of infection with COVID-19 than healthy individuals. However, there is no globally accepted treatment protocol for patients with COAD/COVID-19. Quercetin has been found to have significant antitumor, antiviral and anti-inflammator...
Main Authors: | Xiushen Li, Weizheng Liang, Chengwei Yu, Qingxue Meng, Weiwen Zhang, Xueliang Wu, Jun Xue, Shoulong Deng, Hao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.988153/full |
Similar Items
-
Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection
by: Weizheng Liang, et al.
Published: (2022-05-01) -
Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection
by: Weizheng Liang, et al.
Published: (2022-05-01) -
Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma
by: Chengwei Jiang, et al.
Published: (2022-06-01) -
Exploration of the Shared Gene and Molecular Mechanisms Between Endometriosis and Recurrent Pregnancy Loss
by: Zhuang Ye, et al.
Published: (2022-05-01) -
Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma
by: Wang P, et al.
Published: (2023-02-01)